Designing clinical trials for early (pre-dementia) Alzheimer's disease: Determining the appropriate population for treatment

This publication has 21 references indexed in Scilit:

• Modeling the Cost-Effectiveness of Colorectal Cancer Screening: Policy Guidance Based on Patient Preferences and Compliance
  Cancer Epidemiology, Biomarkers & Prevention, 2009
• Screening for Prostate Cancer — The Controversy That Refuses to Die
  New England Journal of Medicine, 2009
• Mortality Results from a Randomized Prostate-Cancer Screening Trial
  New England Journal of Medicine, 2009
• Screening and Prostate-Cancer Mortality in a Randomized European Study
  New England Journal of Medicine, 2009
• Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms
  Annals of Neurology, 2008
• Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
  Gastroenterology, 2008
• Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial
  Neurology, 2007
• Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
  The Lancet Neurology, 2006
• Toward optimal screening strategies for older women
  Journal of General Internal Medicine, 2005
• Clinical diagnosis of Alzheimer's disease
  Neurology, 1984